Company Q-linea AB

Equities

QLINEA

SE0011527845

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Ratings for Q-linea AB

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Medical Diagnostic & Testing Equipment

Market Closed - Nasdaq Stockholm Other stock markets 11:29:49 2024-04-25 am EDT			5-day change	1st Jan Change
1.998 ^SEK	-0.60%		-2.06%	-46.00%

Mar. 13	Q-linea AB Presents Strong ASTar Results At AMCLI	CI
Feb. 27	Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024

Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.

Number of employees: 127

SEK in Million	2022	Weight	2023	Weight	Delta
Instruments and Consumables 100.0 %	13	100.0 %	4	100.0 %	-65.28%

SEK in Million	2022	Weight	2023	Weight	Delta
European Union 64.3 %	-	-	3	64.3 %	-
United Kingdom 34.3 %	13	100.0 %	2	34.3 %	-88.10%
Sweden 1.4 %	0	0.0 %	0	1.4 %	-

Managers	Title	Age	Since
Jonas Sven Peter Jarvius FOU	Founder	53	08-03-31
Christer Lennart Samuelsson DFI	Director of Finance/CFO	70	23-04-30
Henrik Jacobsson COO	Chief Operating Officer	55	21-12-31
Tiziana di Martino CTO	Chief Tech/Sci/R&D Officer	48	19-07-11
Mats Gullberg CTO	Chief Tech/Sci/R&D Officer	53	-
Jim Kathrein PRN	Corporate Officer/Principal	-	23-07-05
Thomas Fritz PRN	Corporate Officer/Principal	60	19-09-02
Ulrika Stolpe HRO	Human Resources Officer	57	11-12-31

Members of the board	Title	Age	Since
Erika Kjellberg-Eriksson CHM	Chairman	62	11-12-31
Mats Bo Johan Nilsson Bernitz FOU	Founder	54	08-03-31
Hans Olof Gunnar Johansson BRD	Director/Board Member	70	17-12-31
Finn Albrechtsen BRD	Director/Board Member	57	23-06-12
Karin Fischer BRD	Director/Board Member	48	23-06-12
Mario Gualano BRD	Director/Board Member	55	20-05-25
Nina Korfu-Pedersen BRD	Director/Board Member	51	22-05-23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	117,494,844	109,981,576 ( 93.61 %)	328,472 ( 0.2796 %)	93.61 %

Name	Equities	%	Valuation
Aktie-Ansvar AB 1.041 %	1,220,000	1.041 %	244 171 kr
Pareto Asset Management AS 0.0666 %	78,000	0.0666 %	15 611 kr
Anders Lundin 0.0234 %	27,363	0.0234 %	5 476 kr
Mats Gullberg 0.0189 %	22,088	0.0189 %	4 421 kr
Storebrand Asset Management AS 0.0183 %	21,463	0.0183 %	4 296 kr
Case Kapitalförvaltning AB 0.003055 %	3,580	0.003055 %	717 kr
Danske Bank A/S (Investment Management) 0.000282 %	330	0.000282 %	66 kr

Q-linea AB

Dag Hammarskjölds Väg 52 A

752 37, Uppsala

+46 1 84 44 36 10

http://www.qlinea.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
Q-LINEA AB	-46.00%	21.57M
SARTORIUS AG	-15.34%	19.18B
QUIDELORTHO CORPORATION	-46.15%	2.73B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+14.09%	1.84B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-3.39%	1.61B
BIOTAGE AB	+23.19%	1.18B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-10.58%	1B
CONTEC MEDICAL SYSTEMS CO.,LTD	-21.72%	898M
REVENIO GROUP OYJ	-12.15%	710M
VAREX IMAGING CORPORATION	-17.56%	694M

Medical Diagnostic & Testing Equipment